Metabolite Linked to Aggressive Prostate Cancer
February 11, 2009Researchers from the University of Michigan Comprehensive Cancer Center have identified a panel of small molecules, or metabolites, that appear to indicate aggressive prostate cancer.
The finding could lead to a simple test that would help doctors determine which prostate cancers are slow-growing and which require immediate, aggressive treatment.
Results of the study appear in the Feb. 12 issue of Nature.
This video is not supported by your browser at this time.
Researchers from the University of Michigan Comprehensive Cancer Center have identified a panel of small molecules, or metabolites, that appear to indicate aggressive prostate cancer. Credit: University of Michigan Health System
"One of the biggest challenges we face in prostate cancer is determining if the cancer is aggressive. We end up overtreating our patients because physicians don't know which tumors will be slow-growing. With this research, we have identified a potential marker for the aggressive tumors," says senior study author Arul Chinnaiyan, M.D., Ph.D., director of the Michigan Center for Translational Pathology and S.P. Hicks Endowed Professor of Pathology at the U-M Medical School.The researchers looked at 1,126 metabolites across 262 samples of tissue, blood or urine associated with benign prostate tissue, early stage prostate cancer and advanced, or metastatic, prostate cancer. They mapped the alterations in metabolites and identified about 10 that were present more often in prostate cancer than in the benign cells and were present most often in the advanced cancer samples.
"When we're looking at metabolites, we're looking several steps beyond genes and proteins. It allows us to look very deeply at some of the functions of the cells and the biochemistry that occurs during cancer development," says Chinnaiyan, a Howard Hughes Medical Institute investigator.
One metabolite in particular, sarcosine, appeared to be one of the strongest indicators of advanced disease. Levels of sarcosine, an amino acid, were elevated in 79 percent of the metastatic prostate cancer samples and in 42 percent of the early stage cancer samples. Sarcosine was not found at all in the cancer-free samples.
In the study, sarcosine was a better indicator of advancing disease than the traditional prostate specific antigen, or PSA, test that is currently used to monitor or screen for prostate cancer. Sarcosine was detected in the urine, which has researchers hopeful that a simple urine test could be used.
In addition, the researchers found that sarcosine is involved in the same pathways that are linked to cancer invasiveness. This suggests sarcosine as a potential target for future drug development.
"This research gets at characterizing the chemical complexity of a sample of blood. In the future, this science will drive how doctors make treatment recommendations for their patients," says study author Christopher Beecher, Ph.D., professor of pathology at the U-M Medical School.
Results are preliminary at this point and will need years of further testing and development before this technology would be available for patients.
Reference: Nature, Vol. 457, No. 7231, pp. 910-915, Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
Source: University of Michigan Health System
-
Heart disease may be a risk factor for prostate cancer
19 hours ago |
not rated yet |
0
-
Flipping a light switch in the cell: Quantum dots used for targeted neural activation
19 hours ago |
5 / 5 (5) |
1
-
Drugs targeting chromosomal instability may fight a particular breast cancer subtype
Feb 06, 2012 |
5 / 5 (1) |
0
-
Study identifies new prostate cancer drug target
Feb 06, 2012 |
5 / 5 (1) |
0
-
New technology to tackle treatment-resistant cancers
Feb 03, 2012 |
5 / 5 (5) |
2
-
Fast photon control brings quantum photonic technologies closer
1 minute ago |
not rated yet |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (33) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (5) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
-
Oncolytic adenovirus
Feb 04, 2012
-
Nutrition label stuffs and diets
Feb 02, 2012
- More from Physics Forums - Medical Sciences
More news stories
Tenofovir, leading HIV medication, linked with risk of kidney damage
(Medical Xpress) -- Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over ...
Medicine & Health / Medications
1 hour ago |
not rated yet |
0
|
New tumor suppressor gene identified
A recent study published in Clinical Cancer Research suggests that the protein hVps37A suppresses tumor growth in ovarian cancer. The work, which was funded by the Austrian Science Fund FWF, shows, for th ...
43 minutes ago |
4 / 5 (1) |
0
Packard Children's has smallest child yet to get pacemaker
Jaya Maharaj was 15 minutes old when she was sent to surgery at Lucile Packard Childrens Hospital and given a pacemaker that saved her life. The tiny girl born nine weeks early, weighing 3.5 pounds, ...
Medicine & Health / Cardiology
26 minutes ago |
not rated yet |
0
Social psychologist: Lust makes you smarter and evidence that seven deadly sins are good for you
(Medical Xpress) -- Good news for lovers on Valentine’s Day - the seven deadly sins, including Lust, are good for you. University of Melbourne social psychologist Dr Simon Laham uses modern research to make a compelling ...
Medicine & Health / Psychology & Psychiatry
2 hours ago |
4.5 / 5 (2) |
0
Don't ignore kids' snores
(Medical Xpress) -- Your ears arent playing tricks on you that is the sound of snoring you hear from the bedroom of your preschooler. Snoring is common in children, but in some cases it can be a symptom of a ...
1 hour ago |
5 / 5 (1) |
0
Transforming galaxies
(PhysOrg.com) -- Many of the Universe's galaxies are like our own, displaying beautiful spiral arms wrapping around a bright nucleus. Examples in this stunning image, taken with the Wide Field Camera 3 on ...
'Smart' microcapsules in a single step
(PhysOrg.com) -- A new, single-step method of fabricating microcapsules, which have potential commercial applications in industries including medicine, agriculture and diagnostics, has been developed by researchers ...
A continent ablaze in auroral and manmade light
The North American continent is literally set ablaze in a confluence of Auroral and Manmade light captured in spectacular new videos snapped by the astronauts serving aboard the International Space Station ...
Ethanol mandate not the best option
Many people are willing to pay a premium for ethanol, but not enough to justify the government mandate for the corn-based fuel, a Michigan State University economist argues.
Nanostructured electrodes for rechargeable sodium-Ion batteries
Highly efficient 3V cathodes for rechargeable sodium-ion batteries have been developed by users from Argonne National Laboratory's Materials Science, Chemical Sciences & Engineering, and X-ray Sciences Divisions, ...
Feb 11, 2009
Rank: not rated yet
In the meantime doctors rely on highly inaccurate PSA testing, and totally barbaric biopsy and treatment methods.